|
1.
|
Prajapathi ND, Purohit SS, Sharma AK and
Kumar T: A Handbook of Medicinal Plants. 1st edition. Agrobios
India; Jodhpur, India: 2003
|
|
2.
|
British Herbal Pharmacopoeia. 5th edition.
British Herbal Medicine Association; Exeter: 1995
|
|
3.
|
Chevallier A: Encyclopedia of Herbal
Medicine. DK Publishing; New York: 2000
|
|
4.
|
Kew Royal Botanic Gardens: World checklist
of selected plant families. http://apps.kew.org/wcsp/synonomy.do;jsessionid=C2E72FE08A14CAE1130BB94B19007663?name_id=80144uri.
Accessed Apr 5, 2011.
|
|
5.
|
Wiart C: Medicinal Plants of the Asia
Pacific: Drugs for the Future? 1st edition. World Scientific
Publishing Co. Pte. Ltd.; Singapore: 2006
|
|
6.
|
Ogunlesi M, Okiei W, Ofor E and Osibote
AE: Analysis of the essential oil from the dried leaves of
Euphorbia hirta Linn. (Euphorbiaceae), a potential
medication for asthma. African J Biotech. 8:7042–7050. 2009.
|
|
7.
|
Kandalkar AM, Manjunath K, Sholapur HP,
Patel AM and Darade SS: Phytochemical and pharmacognostic
evaluation of Euphorbia hirta Linn. Leaves J Pharm Res.
2:349–352. 2009.
|
|
8.
|
Mahajan R and Badgujar S: Phytochemical
investigations of some laticiferous plants belonging to Khandesh
region of Maharashtra. Ethnobotanical Leaflets. 12:1145–1152.
2008.
|
|
9.
|
Rahmatullah M, Mollik MAH, Azam A, Islam
MR, Chowdhury MAM, Jahan R, et al: Ethnobotanical survey of the
Santal tribe residing in Thakurgaon District, Bangladesh. Am
Eurasian J Sustain Agric. 3:889–898. 2009.
|
|
10.
|
Idu M, Obaruyi G and Erhabor J:
Ethnobotanical uses of plants among the binis in the treatment of
ophthalmic and ENT (ear, nose and throat) ailments. Ethnobotanical
Leaflets. 13:480–496. 2008.
|
|
11.
|
Tona L, Cimanga RK, Mesia K, Musuamba CT,
De Bruyne T, Apers S, et al: In vitro antiplasmodial activity of
extracts and fractions from seven medicinal plants used in the
Democratic Republic of Congo. J Ethnopharmacol. 93:27–32. 2004.
View Article : Google Scholar
|
|
12.
|
Yakubu MT, Akanji MA and Oladiji AT: Male
sexual dysfunction and methods used in assessing medicinal plants
with aphrodisiac potentials. Phcog Rev. 1:49–56. 2007.
|
|
13.
|
Johnson PB, Abdurahman EM, Tiam EA,
Abdu-Aguye I and Hussaini IM: Euphorbia hirta leaf extracts
increase urine output and electrolytes in rats. J Ethnopharmacol.
65:63–69. 1999. View Article : Google Scholar
|
|
14.
|
Hultqvist M, Olofsson P, Gelderman KA,
Holmberg J and Holmdahl R: A new arthritis therapy with oxidative
burst inducers. PLoS Med. 3:e3482006. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Kumar S, Rashmi and Kumar D: Evaluation of
antidiabetic activity of Euphorbia hirta Linn. in
streptozotocin induced diabetic mice. Indian J Nat Prod Resour.
1:200–203. 2010.
|
|
16.
|
Hore SK, Ahuja V, Mehta G, Kumar P, Pandey
SK and Ahmad AH: Effect of aqueous Euphorbia hirta leaf
extract on gastrointestinal motility. Fitoterapia. 77:35–38.
2006.
|
|
17.
|
Adedapo AA, Abatan MO, Idowu SO and
Olorunsogo OO: Effects of chromatographic fractions of Euphorbia
hirta on the rat serum biochemistry. Afr J Biomed Res.
8:185–189. 2005.
|
|
18.
|
Adedapo AA, Abatan MO and Olorunsogo OO:
Toxic effects of some plants in the genus Euphorbia on
haematological and biochemical parameters of rats. Vet Arh.
74:53–62. 2004.
|
|
19.
|
Chee YC: Exploring the effects and
mechanisms of action of Euphorbia hirta extracts on isolated
rat aorta (unpublished Bachelor thesis). International Medical
University,. 2009
|
|
20.
|
University of Bristol: Bristol Veterinary
School: Specimen preparation for electron microscopy. http://www.bristol.ac.uk/vetscience/pathology/labprot/emtechs.htmluri.
Accessed April 24, 2011.
|
|
21.
|
Garcia de Mateos-Verchere J, Vaugeois JM,
Naudin B and Costentin J: Behavioural and neurochemical evidence
that the antimicrobial agent oxolinic acid is a dopamine uptake
inhibitor. Eur Neuropsychopharmacol. 8:255–259. 1998.
|
|
22.
|
Anuradha H, Srikumar BN, Shankaranarayana
Rao BS and Lakshmana M: Euphorbia hirta reverses chronic
stress-induced anxiety and mediates its action through the
GABAA receptor benzodiazepine receptor-Cl−
channel complex. J Neural Transm. 115:35–42. 2008. View Article : Google Scholar
|
|
23.
|
Anuradha H, Srikumar B and Deepti N:
Restoration of acetylcholinesterase activity by Euphorbia
hirta in discrete brain regions of chronically stressed rats.
Pharm Biol. 48:499–503. 2010.PubMed/NCBI
|
|
24.
|
Lanhers MC, Fleurentin J, Mortier F,
Misslin R and Cabalin P: Behavioural and neurotropic effects of an
aqueous extract of Euphorbia hirta L. (Euphorbiaceae). Actes
du Colloque Europeen d’Ethnopharmacologie et de la 11th Conférence
internationale d’Ethnomedecine; Heidelberg. 24–27 March 1993;
|
|
25.
|
Akaike N, Shirasaki T and Yakushiji T:
Quinolones and fenbufen interact with GABAA receptor in
dissociated hippocampal cells of rat. J Neurophysiol. 66:497–504.
1991.
|
|
26.
|
Unseld E, Ziegler G, Gemeinhardt A,
Janssen U and Klotz U: Possible interaction of fluoroquinolones
with the benzodiazepine-GABAA-receptor complex. Br J
Clin Pharmacol. 30:63–70. 1990. View Article : Google Scholar
|
|
27.
|
US Food Drug Administration: Risk of
fluoroquinolone-associated myasthenia gravis exacerbation -
February 2011 label changes for fluoroquinolones. http://www.fda.gov/safety/medwatch/safetyinformation/ucm247115.htmuri.
Accessed October 20, 2011.
|
|
28.
|
Titanji VPK, Zofou D and Ngemenya MN: The
antimalarial potential of medicinal plants used for the treatment
of malaria in Cameroonian folk medicine. Afr J Tradit Complement
Altern Med. 5:302–321. 2008.PubMed/NCBI
|
|
29.
|
Rubinstein E: History of quinolones and
their side effects. Chemotherapy. 47(Suppl 3): 3–8. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Boelaert J, de Jaegere PP, Daneels R,
Schurgers M, Gordts B and Van Landuyt HW: Case report of renal
failure during norfloxacin therapy. Clin Nephrol.
25:2721986.PubMed/NCBI
|
|
31.
|
Hanson B, D’Hondt A, Depierreux M and
Lustman F: Nephrotic syndrome after norfloxacin. Nephron.
74:4461996. View Article : Google Scholar : PubMed/NCBI
|
|
32.
|
Hestin D, Hanesse B, Frimat L, Renaudin
JM, Netter P and Kessler M: Norfloxacin-induced nephrotic syndrome.
Lancet. 345:732–733. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
33.
|
Nakamura M, Ohishi A, Aosaki N and
Hamaguchi K: Norfloxacin-induced acute interstitial nephritis.
Nephron. 86:204–205. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
34.
|
Goldstein EJ: Possible role for the new
fluoroquinolones (levofloxacin, grepafloxacin, trovafloxacin,
clinafloxacin, sparfloxacin, and DU-6859a) in the treatment of
anaerobic infections: review of current information on efficacy and
safety. Clin Infect Dis. 23(Suppl 1): S25–30. 1996. View Article : Google Scholar
|
